Published in Dermatology on January 01, 1995
Chemotherapy-associated supravenous hyperpigmentation. Dermatology (1996) 0.83
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol (2012) 2.67
Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66
Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1998) 2.41
A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today (1998) 2.19
Lupus erythematosus tumidus--a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol (2000) 2.09
High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol (1997) 1.96
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol (2005) 1.90
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73
Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73
Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64
Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol (2010) 1.63
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol (2009) 1.60
Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol (1999) 1.59
Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia. J Invest Dermatol (1999) 1.58
Acquired syphilis II in early childhood: reappearance of syphilis brephotrophica. J Am Acad Dermatol (1998) 1.49
[Sudden greying or whitening of the scalp hair]. Dtsch Med Wochenschr (1995) 1.45
A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43
Red lunulae in severe alopecia areata. Acta Derm Venereol (1992) 1.42
Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet (1998) 1.41
The hand eczema proteome: imbalance of epidermal barrier proteins. Br J Dermatol (2015) 1.40
Efficacy and skin tolerability of Saliker in the treatment of dandruff. Eur J Dermatol (2002) 1.40
Papular-purpuric 'gloves and socks' syndrome associated with human herpesvirus 6 infection. Arch Dermatol (1998) 1.40
Persistent granulomatous plaque type zoster in a patient with HIV infection. Int J Dermatol (2011) 1.38
[The differential diagnosis of nodular tumors of the hand]. Dtsch Med Wochenschr (1994) 1.38
Assessing the effectiveness of Dead Sea products. Isr Med Assoc J (2007) 1.37
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol (2000) 1.32
Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem (1999) 1.31
Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A (2000) 1.28
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol (2009) 1.26
Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24
Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol (2001) 1.20
Congenital erythropoietic porphyria. J Am Acad Dermatol (1997) 1.17
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol (2002) 1.15
Arylhydrocarbon hydroxylase activity in lymphocytes of patients with psoriasis. Lancet (1980) 1.14
Nitric oxide in human skin: current status and future prospects. J Invest Dermatol (1998) 1.13
Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol (2012) 1.08
Type 1 segmental cutaneous leiomyomatosis. Clin Exp Dermatol (2002) 1.07
Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett (1992) 1.05
Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol (2012) 1.05
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol (1986) 1.04
Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet (1996) 1.04
Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol (2010) 1.04
A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med (1996) 1.04
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol (1998) 1.04
Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol (1983) 1.02
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol (1993) 1.02
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum (2007) 1.01
Dapsone in the treatment of lupus erythematosus. Br J Dermatol (1981) 0.99
Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol (1998) 0.99
Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol (1998) 0.99
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.99
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol (1998) 0.99
Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol (1997) 0.98
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol (1995) 0.97
MSH6 mutation in Muir-Torre syndrome: could this be a rare finding? Br J Dermatol (2007) 0.96
Defects of mitochondrial respiratory chain in multiple symmetric lipomatosis. Arch Dermatol Res (1998) 0.96
An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol (2009) 0.96
Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch (2000) 0.96
Pyoderma gangrenosum after cesarean delivery. Am J Obstet Gynecol (2000) 0.94
Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci (1998) 0.94
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol (2000) 0.94
Plantar malignant melanoma -- a challenge for early recognition. Melanoma Res (2000) 0.94
Treatment of atopic eczema with oral alitretinoin. Br J Dermatol (2009) 0.93
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol (2001) 0.93
Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol (1998) 0.93
Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol (1997) 0.93
Surgical pearl: nail splinting by flexible tube--a new noninvasive treatment for ingrown toenails. J Am Acad Dermatol (1998) 0.93
Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem Photobiol (1997) 0.93
Chronic cutaneous damage after accidental exposure to ionizing radiation: the Chernobyl experience. J Am Acad Dermatol (1994) 0.92
Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol (2015) 0.92
Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result. J Eur Acad Dermatol Venereol (2014) 0.92
Vitamin D and its role in allergic disease. Clin Exp Allergy (2012) 0.92
Psoriasis: the plot thickens.... Nat Immunol (2001) 0.92
Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade). Br J Dermatol (2004) 0.92
Topical tacrolimus for pyoderma gangrenosum. Lancet (1998) 0.92
Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation. Radiat Res (1993) 0.92
Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases. J Eur Acad Dermatol Venereol (2007) 0.91
Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol (1999) 0.91
Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. J Allergy Clin Immunol (1983) 0.90
Photodynamic therapy in dermatology. Arch Dermatol (1998) 0.90
Arachidonic acid metabolism in guinea pig skin. Biochim Biophys Acta (1982) 0.90
Topical immunomodulators--progress towards treating inflammation, infection, and cancer. Lancet Infect Dis (2001) 0.90
[Benign symmetric Launois-Bensaude type III lipomatosis and Bureau-Barrière syndrome]. Hautarzt (1991) 0.90
Arachidonic acid metabolism in skin: a review. Rev Physiol Biochem Pharmacol (1984) 0.89
High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line. J Invest Dermatol (1990) 0.89
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol (2008) 0.89
Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol (1999) 0.89
Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol (2012) 0.89
Cellular schwannoma. Am J Dermatopathol (1994) 0.88
Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family. J Mol Biol (1999) 0.88
Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser. J Am Acad Dermatol (2000) 0.88
Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. J Am Acad Dermatol (2001) 0.88